Contact
searchSearch
HMP Global

June 2012 - FRMC

Flu Vaccine Less Effective among Elderly
06/19/2012
Eileen Koutnik-Fotopoulos
Morbidity from influenza is significant in people ³65 years of age. As a result, annual vaccination is recommended to reduce the burden of influenza in this patient population. New analysis suggests, however, that the influenza vaccination...
Morbidity from influenza is significant in people ³65 years of age. As a result, annual vaccination is recommended to reduce the burden of influenza in this patient population. New analysis suggests, however, that the influenza vaccination...
Morbidity from influenza is...
06/19/2012
First Report Managed Care
Department
Optimal Response to Natalizumab in MS Patients
06/19/2012
Eileen Koutnik-Fotopoulos
Results from a small study found that inhibition of intrathecal antibody synthesis is associated with a complete therapeutic response to natalizumab in patients with aggressive multiple sclerosis (MS). Treatment with natalizumab decreased the...
Results from a small study found that inhibition of intrathecal antibody synthesis is associated with a complete therapeutic response to natalizumab in patients with aggressive multiple sclerosis (MS). Treatment with natalizumab decreased the...
Results from a small study found...
06/19/2012
First Report Managed Care
Department
Better Prevention of Clostridium Difficile Infections Needed
06/19/2012
Mary Beth Nierengarten
Most of the substantial increase in Clostridium difficile infections (CDIs) over the past decade in the United States is related to healthcare exposures that may be prevented by reducing unnecessary antibiotic use and interrupting...
Most of the substantial increase in Clostridium difficile infections (CDIs) over the past decade in the United States is related to healthcare exposures that may be prevented by reducing unnecessary antibiotic use and interrupting...
Most of the substantial increase...
06/19/2012
First Report Managed Care
Department
Adult Vaccination Strategies for Invasive Pneumococcal Disease
06/19/2012
Kevin L. Carter
Although the 23-valent pneumococcal polysaccharide vaccine (PPSV23) has been recommended for prevention of invasive pneumococcal disease (IPD) in adults since 1983, there have been no conclusive assessments of its ability to prevent...
Although the 23-valent pneumococcal polysaccharide vaccine (PPSV23) has been recommended for prevention of invasive pneumococcal disease (IPD) in adults since 1983, there have been no conclusive assessments of its ability to prevent...
Although the 23-valent...
06/19/2012
First Report Managed Care
Migraine-Related Direct Medical Costs Lower with OnabotulinumtoxinA
06/19/2012
Eileen Koutnik-Fotopoulos
New Orleans—Chronic migraine (CM) patients treated with onabotulinumtoxinA reported a significant decline in emergency department (ED) visits. The results were presented at the AAN meeting during a poster session. The poster was titled...
New Orleans—Chronic migraine (CM) patients treated with onabotulinumtoxinA reported a significant decline in emergency department (ED) visits. The results were presented at the AAN meeting during a poster session. The poster was titled...
New Orleans—Chronic migraine...
06/19/2012
First Report Managed Care
Migraine Guidelines Evaluate Efficacy of Treatments
06/19/2012
Eileen Koutnik-Fotopoulos
Despite many treatments available to help prevent migraine in certain people, most migraine sufferers do not use them.
Despite many treatments available to help prevent migraine in certain people, most migraine sufferers do not use them.
Despite many treatments...
06/19/2012
First Report Managed Care
Containing Costs Through Healthcare Reform
06/19/2012
Tim Casey
Healthcare spending in the United States has reached $2.25 trillion, accounting for 16% of the country’s gross domestic product (GDP). 
Healthcare spending in the United States has reached $2.25 trillion, accounting for 16% of the country’s gross domestic product (GDP). 
Healthcare spending in the...
06/19/2012
First Report Managed Care
Options to Prevent Strokes in Patients with Atrial Fibrillation
06/19/2012
Tim Casey
Orlando—Patients with atrial fibrillation (AF) typically take warfarin to prevent strokes, but pharmaceutical companies are investing significant time and money to find alternative therapies. The FDA approved Pradaxa® (dabigatran etexilate)...
Orlando—Patients with atrial fibrillation (AF) typically take warfarin to prevent strokes, but pharmaceutical companies are investing significant time and money to find alternative therapies. The FDA approved Pradaxa® (dabigatran etexilate)...
Orlando—Patients with atrial...
06/19/2012
First Report Managed Care
Medical Homes as Centerpiece of Healthcare Reform
06/19/2012
Tim Casey
Orlando—In nearly 5 decades as a doctor, Sam JW Romeo has seen numerous industry innovations that did not improve care or cut costs. He is now the medical director at Tower Health & Wellness Center in Turlock, California, which he and other...
Orlando—In nearly 5 decades as a doctor, Sam JW Romeo has seen numerous industry innovations that did not improve care or cut costs. He is now the medical director at Tower Health & Wellness Center in Turlock, California, which he and other...
Orlando—In nearly 5 decades as a...
06/19/2012
First Report Managed Care

Department

Conference Insider
Implementation of Accountable Care Organizations
06/19/2012
Tim Casey
Orlando—Soon after the Department of Health and Human Services (HHS) announced the proposed regulations for accountable care organizations (ACOs) in March 2011, many constituencies in the healthcare industry derided the rules as too...
Orlando—Soon after the Department of Health and Human Services (HHS) announced the proposed regulations for accountable care organizations (ACOs) in March 2011, many constituencies in the healthcare industry derided the rules as too...
Orlando—Soon after the...
06/19/2012
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

News
Current Understandings of Disease Mechanisms and Therapeutic Approaches in Multiple Sclerosis
10/23/2024
Juliet Gallagher
A comprehensive review of multiple sclerosis causes, forms, and treatments.
A comprehensive review of multiple sclerosis causes, forms, and treatments.
A comprehensive review of...
10/23/2024
First Report Managed Care
News
Monoclonal Antibody Improves Type 2 Inflammation Biomarkers in Children With Asthma
04/21/2023
Jolynn Tumolo
Findings from a phase 3 study suggest two dose regimens of a monoclonal antibody were similarly efficacious for reducing type 2 inflammatory biomarkers in pediatric patients with asthma.
Findings from a phase 3 study suggest two dose regimens of a monoclonal antibody were similarly efficacious for reducing type 2 inflammatory biomarkers in pediatric patients with asthma.
Findings from a phase 3 study...
04/21/2023
First Report Managed Care
News
Survival Disparity Persists Between Black and White Patients With CLL
05/19/2023
Jolynn Tumolo
When compared to White patients, Black patients with chronic lymphocytic leukemia face a persistent survival disadvantage that is not found among other racial minority groups, researchers reported.
When compared to White patients, Black patients with chronic lymphocytic leukemia face a persistent survival disadvantage that is not found among other racial minority groups, researchers reported.
When compared to White patients,...
05/19/2023
First Report Managed Care
News
Therapy Improves Type 2 Asthma Outcomes Regardless of Allergic Status
06/09/2023
Jolynn Tumolo
Researchers found that long-term treatment with dupilumab improved outcomes in patients with moderate-to-severe GINA-based type 2 asthma, regardless of allergic status.
Researchers found that long-term treatment with dupilumab improved outcomes in patients with moderate-to-severe GINA-based type 2 asthma, regardless of allergic status.
Researchers found that long-term...
06/09/2023
First Report Managed Care
News
Measuring RSV Risk Awareness Among Adults With Diabetes
07/07/2023
Julie Gould
Researchers explored knowledge, attitudes, and perceptions of respiratory syncytial virus (RSV) risk among US adults with diabetes to inform health care provider education efforts related to RSV awareness.
Researchers explored knowledge, attitudes, and perceptions of respiratory syncytial virus (RSV) risk among US adults with diabetes to inform health care provider education efforts related to RSV awareness.
Researchers explored knowledge,...
07/07/2023
Pharmacy Learning Network

June 2012 Volume 9 Issue 6

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use